| Amanda Maureen Bastian, | |
|
205 S Haynes Ave, Miles City, MT 59301-4779 | |
| (406) 233-4327 | |
| Not Available |
| Full Name | Amanda Maureen Bastian |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 205 S Haynes Ave, Miles City, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467205641 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-SP-LIC-4962 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Maureen Bastian, 205 S Haynes Ave, Miles City, MT 59301-4779 Ph: (406) 233-4327 | Amanda Maureen Bastian, 205 S Haynes Ave, Miles City, MT 59301-4779 Ph: (406) 233-4327 |
News Archive
As youth baseball season gets into full swing, Tony Wanich, MD, Attending Surgeon, Department of Orthopaedic Surgery at Montefiore Medical Center offers tips for parents and coaches to help prevent injuries which could require surgery later in life.
Iverson Genetic Diagnostics, Inc. announced today an exclusive licensing agreement with Johns Hopkins University School of Medicine under which Iverson receives global exclusive commercialization rights for molecular diagnostics that are designed to help physicians to assess cardiovascular risk in men and women and infertility risk in women.
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
Regeneron Pharmaceuticals, Inc. and Astellas Pharma Inc. announced that Astellas has extended through 2023 the non-exclusive license agreement that allows Astellas to utilize Regeneron's VelocImmune® technology in its internal research programs to discover fully human monoclonal antibody product candidates.
The Murdoch Children's Research Institute and University of Melbourne researchers discovered a two-pronged blood test will confirm peanut allergies instead of putting children through risky oral food challenge tests.
› Verified 5 days ago
Tana Thorley Whicker, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 S Haynes Ave Unit 2, Miles City, MT 59301 Phone: 406-233-4327 Fax: 406-233-3985 | |
Marilyn Joyce Thaden, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 3151, Miles City, MT 59301 Phone: 406-234-5275 | |
Pearl Hamano, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Wilson St, Therapy Services Dept., Miles City, MT 59301 Phone: 406-233-2719 | |
Sarah Lynn Waarvik, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 611 S Strevell Ave, Miles City, MT 59301 Phone: 406-370-0116 | |
Joanna Buchholz, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Box Elder St, Miles City, MT 59301 Phone: 406-234-6034 Fax: 406-234-7018 | |
Megan M Emmons, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Wilson Street, Miles City, MT 59301 Phone: 406-233-2719 |